Your browser doesn't support javascript.
loading
Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy.
Béziat, Vivien; Rapaport, Franck; Hu, Jiafen; Titeux, Matthias; Bonnet des Claustres, Mathilde; Bourgey, Mathieu; Griffin, Heather; Bandet, Élise; Ma, Cindy S; Sherkat, Roya; Rokni-Zadeh, Hassan; Louis, David M; Changi-Ashtiani, Majid; Delmonte, Ottavia M; Fukushima, Toshiaki; Habib, Tanwir; Guennoun, Andrea; Khan, Taushif; Bender, Noemi; Rahman, Mahbuba; About, Frédégonde; Yang, Rui; Rao, Geetha; Rouzaud, Claire; Li, Jingwei; Shearer, Debra; Balogh, Karla; Al Ali, Fatima; Ata, Manar; Dabiri, Soroosh; Momenilandi, Mana; Nammour, Justine; Alyanakian, Marie-Alexandra; Leruez-Ville, Marianne; Guenat, David; Materna, Marie; Marcot, Léa; Vladikine, Natasha; Soret, Christine; Vahidnezhad, Hassan; Youssefian, Leila; Saeidian, Amir Hossein; Uitto, Jouni; Catherinot, Émilie; Navabi, Shadi Sadat; Zarhrate, Mohammed; Woodley, David T; Jeljeli, Mohamed; Abraham, Thomas; Belkaya, Serkan.
Afiliación
  • Béziat V; University of Paris, Imagine Institute, INSERM U1163, 75015 Paris, France; The Rockefeller University, New York, NY 10065, USA. Electronic address: vivien.beziat@inserm.fr.
  • Rapaport F; The Rockefeller University, New York, NY 10065, USA.
  • Hu J; Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
  • Titeux M; University of Paris, Imagine Institute, INSERM U1163, 75015 Paris, France.
  • Bonnet des Claustres M; University of Paris, Imagine Institute, INSERM U1163, 75015 Paris, France.
  • Bourgey M; McGill University, Montreal, QC H3A 0G1, Canada.
  • Griffin H; University of Cambridge, Cambridge CB2 1QP, UK.
  • Bandet É; University of Paris, Imagine Institute, INSERM U1163, 75015 Paris, France.
  • Ma CS; Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia; St. Vincent's Clinical School, UNSW Sydney, Sydney, NSW 2052, Australia.
  • Sherkat R; Isfahan University of Medical Sciences, AIRC, Isfahan 81746-73461, Iran.
  • Rokni-Zadeh H; Zanjan University of Medical Sciences, Zanjan 45139-56184, Iran.
  • Louis DM; Stanford University Medical School, Stanford, CA 94305, USA.
  • Changi-Ashtiani M; Institute for Research in Fundamental Sciences (IPM), Tehran 19395-5746, Iran.
  • Delmonte OM; National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.
  • Fukushima T; Institute of Innovative Research, Tokyo Institute of Technology, Yokohama 226-8501, Japan.
  • Habib T; Sidra Medicine, Doha, Qatar.
  • Guennoun A; Sidra Medicine, Doha, Qatar.
  • Khan T; Sidra Medicine, Doha, Qatar.
  • Bender N; German Cancer Research Center, 69120 Heidelberg, Germany.
  • Rahman M; Sidra Medicine, Doha, Qatar.
  • About F; University of Paris, Imagine Institute, INSERM U1163, 75015 Paris, France.
  • Yang R; The Rockefeller University, New York, NY 10065, USA.
  • Rao G; Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia; St. Vincent's Clinical School, UNSW Sydney, Sydney, NSW 2052, Australia.
  • Rouzaud C; University of Paris, Imagine Institute, INSERM U1163, 75015 Paris, France; Necker Hospital for Sick Children, AP-HP, 75015 Paris, France.
  • Li J; Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
  • Shearer D; Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
  • Balogh K; Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
  • Al Ali F; Sidra Medicine, Doha, Qatar.
  • Ata M; Sidra Medicine, Doha, Qatar.
  • Dabiri S; Zahedan University of Medical Sciences, 054 Zahedan, Iran.
  • Momenilandi M; University of Leuven, 3000 Leuven, Belgium.
  • Nammour J; University of Paris, Imagine Institute, INSERM U1163, 75015 Paris, France.
  • Alyanakian MA; Necker Hospital for Sick Children, AP-HP, 75015 Paris, France.
  • Leruez-Ville M; Necker Hospital for Sick Children, AP-HP, 75015 Paris, France.
  • Guenat D; Papillomavirus National Reference Center, Besançon Hospital, 25030 Besançon, France.
  • Materna M; University of Paris, Imagine Institute, INSERM U1163, 75015 Paris, France.
  • Marcot L; University of Paris, Imagine Institute, INSERM U1163, 75015 Paris, France.
  • Vladikine N; University of Paris, Imagine Institute, INSERM U1163, 75015 Paris, France.
  • Soret C; Papillomavirus National Reference Center, Besançon Hospital, 25030 Besançon, France.
  • Vahidnezhad H; Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Youssefian L; Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Saeidian AH; Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Uitto J; Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Catherinot É; Foch Hospital, 92150 Suresnes, France.
  • Navabi SS; Dr. Shahrooei Lab, Ahvaz, Iran.
  • Zarhrate M; University of Paris, Imagine Institute, INSERM U1163, 75015 Paris, France.
  • Woodley DT; University of Southern California, Los Angeles, CA 90033, USA.
  • Jeljeli M; Cochin University Hospital, AP-HP, 75014 Paris, France.
  • Abraham T; Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
  • Belkaya S; The Rockefeller University, New York, NY 10065, USA.
Cell ; 184(14): 3812-3828.e30, 2021 07 08.
Article en En | MEDLINE | ID: mdl-34214472
ABSTRACT
We study a patient with the human papilloma virus (HPV)-2-driven "tree-man" phenotype and two relatives with unusually severe HPV4-driven warts. The giant horns form an HPV-2-driven multifocal benign epithelial tumor overexpressing viral oncogenes in the epidermis basal layer. The patients are unexpectedly homozygous for a private CD28 variant. They have no detectable CD28 on their T cells, with the exception of a small contingent of revertant memory CD4+ T cells. T cell development is barely affected, and T cells respond to CD3 and CD2, but not CD28, costimulation. Although the patients do not display HPV-2- and HPV-4-reactive CD4+ T cells in vitro, they make antibodies specific for both viruses in vivo. CD28-deficient mice are susceptible to cutaneous infections with the mouse papillomavirus MmuPV1. The control of HPV-2 and HPV-4 in keratinocytes is dependent on the T cell CD28 co-activation pathway. Surprisingly, human CD28-dependent T cell responses are largely redundant for protective immunity.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Papillomaviridae / Piel / Linfocitos T / Antígenos CD28 / Patrón de Herencia Límite: Adult / Animals / Child / Female / Humans / Male Idioma: En Revista: Cell Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Papillomaviridae / Piel / Linfocitos T / Antígenos CD28 / Patrón de Herencia Límite: Adult / Animals / Child / Female / Humans / Male Idioma: En Revista: Cell Año: 2021 Tipo del documento: Article